125 related articles for article (PubMed ID: 3066876)
21. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
22. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
[TBL] [Abstract][Full Text] [Related]
24. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
25. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
26. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
Li GH; Qu MR; Wan JZ; You JM
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
[TBL] [Abstract][Full Text] [Related]
27. [Mechanisms of action of angiotensin I converting enzyme inhibitors].
Wiecek A
Przegl Lek; 1994; 51(4):193-7. PubMed ID: 8058992
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of inhibitors of the renin-angiotensin system.
Fouad-Tarazi FM
J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
[TBL] [Abstract][Full Text] [Related]
30. [Clinical findings with inhibitors of the renin-angiotensin system].
Dietz R; Süsselbeck T; Osterziel KJ
Arzneimittelforschung; 1993 Feb; 43(2A):265-70. PubMed ID: 8498976
[TBL] [Abstract][Full Text] [Related]
31. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
Neutel JM
J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
[TBL] [Abstract][Full Text] [Related]
32. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.
Abdelrahman AM; Burrell LM; Johnston CI
J Hypertens Suppl; 1993 Apr; 11(3):S23-6. PubMed ID: 8315514
[TBL] [Abstract][Full Text] [Related]
33. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
34. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
[TBL] [Abstract][Full Text] [Related]
35. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
Dzau VJ
Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
[TBL] [Abstract][Full Text] [Related]
36. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
Anastasopoulos F; Leung R; Kladis A; James GM; Briscoe TA; Gorski TP; Campbell DJ
J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
[TBL] [Abstract][Full Text] [Related]
37. Feedback analysis of the behavior of the renin-angiotensin system under inhibition of angiotensin-converting enzyme.
Wada T; Aoyagi T; Iinuma H; Ogawa K; Kojima F; Nagai M; Kuroda H; Obayashi A; Takeuchi T
Biotechnol Appl Biochem; 1988 Oct; 10(5):435-46. PubMed ID: 3058152
[TBL] [Abstract][Full Text] [Related]
38. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.
Weber MA; Neutel JM; Smith DH
Am Heart J; 1992 May; 123(5):1414-20. PubMed ID: 1575168
[TBL] [Abstract][Full Text] [Related]
39. Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
Nussberger J; Waeber B; Brunner HR
Am J Hypertens; 1989 Apr; 2(4):286-93. PubMed ID: 2650711
[TBL] [Abstract][Full Text] [Related]
40. The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors.
Bönner G
Drugs; 1997; 54 Suppl 5():23-30. PubMed ID: 9429842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]